J. Matthew Singleton, Director of Viking Therapeutics VKTX, has filed 0 purchases and 11 sales on the open market. The latest trade was on 01/02.

JS

JS

J. Matthew Singleton

Director

Company

Viking Therapeutics VKTX

First filing

23/01/04

Trades

26 trades

Buys / sales

0 / 11

12-month net buying

No record

Last trade

01/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Viking TherapeuticsVKTX	Open-market sale10b5-1 plan	24/10/25	24/10/25	16,000 sh	$79.50	$1,272,000	−62.7%
Viking TherapeuticsVKTX	Open-market sale10b5-1 plan	24/09/20	24/09/20	10,300 sh	$69.50	$715,850	−52.0%
Viking TherapeuticsVKTX	Open-market sale10b5-1 plan	24/08/21	24/08/22	5,700 sh	$69.72	$397,404	−37.5%
Viking TherapeuticsVKTX	Open-market sale10b5-1 plan	24/08/19	24/08/19	16,000 sh6 trades	$62.22avg.	$995,443.78	−62.7%
Viking TherapeuticsVKTX	Open-market sale10b5-1 plan	24/08/14	24/08/14	20,786 sh2 trades	$57.53avg.	$1,195,746.72	−68.6%